(ALKS:Consolidated Issue Listed on NASDAQ Global Select )
Earnings & Estimates Summary - ALKERMES PLC (ALKS)
2013 revenues at Alkermes plc totaled $596.3M USD, while annual earnings equaled $1.19 per share.
Quarterly Earnings & Estimates - ALKERMES PLC (ALKS)
Alkermes plc's Quarterly Earnings
Alkermes plc reported 2nd quarter 2014 earnings of $0.11 per share on 08/2/2014.
Annual Earnings & Estimates - ALKERMES PLC (ALKS)
Alkermes plc's Annual Earnings
Alkermes plc reported annual 2013 earnings of $1.19 per share on 03/1/2014.
Quarterly Revenues - ALKERMES PLC (ALKS)
Alkermes plc's Quarterly Revenues
Alkermes plc had 2nd quarter 2014 revenues of $153.4M USD. This bettered the $148.2M USD consensus of the 10 analysts covering the company. This was 10.7% above the prior year's 2nd quarter results.
Annual Revenues - ALKERMES PLC (ALKS)
Alkermes plc's Annual Revenues
Alkermes plc had revenues for the full year 2013 of $596.3M USD. This was 52.9% above the prior year's results.
|Cosmo Pharmaceuticals SA||SFr.163.70 CHF||-2.60|
|Emergent Biosolutions Inc||$31.86 USD||+0.11|
|Jazz Pharmaceuticals PLC||$179.35 USD||-0.58|
|Nektar Therapeutics||$11.50 USD||-0.02|
|Pacira Pharmaceuticals Inc/DE||$78.21 USD||-1.87|
|View Industry Companies|